ArchiMed is an asset management company registered under RCS Lyon 795 309 525 with a share capital of 175 000€, with headquarters at 2 Place de Francfort, 69003 Lyon. ArchiMed is registered with the Autorité des Marchés Financiers (AMF) under N° GP-14000002.
The purpose of this website is to provide general information on ArchiMed SAS’ activities. ArchiMed SAS may not be held responsible for any errors or omissions in the information provided on the website. More generally, ArchiMed SAS accepts no responsibility for any damage, direct or indirect, whatever the cause, origin, nature or consequence, caused by the access of anyone to the website or the impossibility of accessing it, or by the use of the website and/or the credit given to any information coming directly or indirectly from this website.
Unless otherwise stated this website is neither a binding commitment, an offer to buy or sell any asset, nor a solicitation for an offer to buy or sell an asset.
ArchiMed SAS is not liable for any hypertext links to companies. Links to this website are not permitted without the prior written agreement of ArchiMed SAS.
As required by AMF Instruction n°2012-07, claims handling will guarantee the application of transparent, free of charge and objective principles towards the customer. Written claims should be submitted by mail to the following address:
ArchiMed SAS, 2 Place de Francfort, 69003 Lyon – France
Unless otherwise stated, the intellectual property rights of the documents on the website and all other elements created for this website are the sole property of ArchiMed SAS, who grants no license or right other than that of consulting the Site. The reproduction of all documents published on the website (in particular the photographs, films and animations) is solely authorized for information purposes only for personal and private use. Any reproduction and any use of copies made for other purposes are expressly prohibited
This English-language version of the legal notice below is a free translation of the original French text. It is not the governing version. In the event of a conflict of interpretation, reference must be made to the French version which is the governing version. The user acknowledges having taken note of these conditions of use and having understood them, and undertakes to comply with them.
We have integrated within our due diligence process an ESG (Environmental, Social and Governance) process. This initiative is fundamental to our overall investment strategy. We are convinced that the integration of non-financial elements in our investment strategy is essential in order to create long term value for our investors, our portfolio companies and our partners. We encourage the companies we invest in to adopt the best policies in this area.
We have created within our management company an ESG improvement policy for our internal procedures in order for us to reduce our carbon footprint and so that we can improve our social and governmental impact.
The voting policy of the management company is available to the investors at the headquarters of the company.
Best selection/ best execution policy
To date, ArchiMed completes transactions on financial instruments that are not admitted to trading on a regulated market. Thus no best selection/ best execution policy has been implemented yet.
Conflict of interest policy
The conflict of interest policy of the management company is available to the investors at the headquarters of the company.
Maximum claim processing
ArchiMed undertakes to acknowledge receipt of any claim within the 10 following working days, by any means. ArchiMed undertakes to respond to any claim within a maximum period of 2 months, except in case of the occurrence of duly justified specific circumstances.
In case of dissatisafaction regarding the treatment of your claim, you can contact the independant mediator of the A.M.F at the following address :
Médiateur de l’AMF
17, place de la bourse
75082 PARIS CEDEX 02
Fax : 01.53.45.59.60